Paul Ehrlich Institute / Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel (PEI)

Research facility


Location: Langen, Germany (DE) DE

ISNI: 0000000110190926

ROR: https://ror.org/00yssnc44

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Insights into Api m 10-Isoforms and Splice Variants: More Than One Major IgE-Binding Epitope (2026) Paulus-Tremel KE, Wolff MB, Novak N, Wagner N, Landgraf A, Schülke S, Holzhauser T, Mahler V Journal article Clinical trials with interim analyses: standardizing terminology to increase clarity (2025) Asikanius E, Hofner B, Hampson LV, Wassmer G, Jennison C, Mielke T, Kunz CU, Rufibach K Journal article Variability in Paediatric Patch Test Practices Across Europe: A Survey From the European Baseline Series (EBS) Working Party on Behalf of the European Society of Contact Dermatitis (ESCD) (2025) Aerts O, Rustemeyer T, Belloni-Fortina A, Badulici S, Dickel H, Garcia Abujeta JL, Giménez-Arnau AM, et al. Journal article T-bet+ B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms (2024) Rauch E, Amendt T, Lopez Krol A, Lang FB, Linse V, Hohmann M, Keim AC, et al. Journal article Marketing authorisation for rare diseases: The European regulatory perspective using the example of gene and cell therapies Arzneimittelzulassung im Bereich seltener Erkrankungen: die europäische regulatorische Perspektive am Beispiel der Gen- und Zelltherapeutika (2024) Schüßler-Lenz M, Hofner B Journal article Möglichkeiten der Fertigung von Testallergenen in öffentlichen Apotheken zur Diagnostik von Typ I-Allergien – rechtliche Aspekte (2024) Jost R, Kespohl S, Paulus-Tremel KE, Zimmer J, Bonertz A, Sander I, Klose T, et al. Journal article, Review article The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effects (2024) Ertl C, Ruf T, Mentzer D, Kong M, Kramer R, Bergwelt-Baildon Mv, Subklewe M, et al. Journal article Possible manufacture of test allergens in public pharmacies for the diagnosis of type I allergies: Legal aspects (2024) Jost R, Kespohl S, Paulus-Tremel KE, Zimmer J, Bonertz A, Sander I, Klose T, et al. Journal article, Review article Establishment of an ELISA-based in vitro test system to quantify the major honey bee venom allergen Api m 10 in crude bee venoms and therapy allergen products (2024) Landgraf A, Hein S, Paulus-Tremel KE, Wolff MB, Arend M, Junker AC, Strecker D, et al. Journal article IL-10-modulated dendritic cells from birch pollen- and hazelnut-allergic patients facilitate Treg-mediated allergen-specific and cross-reactive tolerance (2024) Heinl PV, Graulich E, Weigmann B, Wangorsch A, Ose R, Bellinghausen I, Khatri R, et al. Journal article
‹ 1 2 3 ... 8 ›